Effect of high-fat diet on KKAy and ob/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations

Hormone and Metabolic Research

Volumn 37, Issue 7, 2005, Pages 402-407

  Alberts, P ^a,b   Ronquist Nii Y ^a   Larsson, C ^a   Klingstrom G ^a   Engblom, L ^a   Edling, N ^a   Lidell, V ^a   Berg, I ^a   Edlund, P O ^a   Ashkzari, M ^a   Sahaf, N ^a   Norling, S ^a   Berggren, V ^a   Bergdahl, K ^a   Forsgren, M ^a   Abrahmsen L ^a  

^a Biovitrum ^*  (Sweden)

^b Affibody AB   (Sweden)

Author keywords

11 Hydroxysteroid dehydrogenase type 1 (11 HSD1); 11 Dehydrocorticosterone; Corticosterone; Diabetes; Glucocorticoids; Metabolic syndrome; Obesity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; DEHYDROCORTICOSTERONE; GLUCOCORTICOID;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; EPIDIDYMIS FAT; LIPID DIET; LIVER; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHROMATOGRAPHY, LIQUID; CORTICOSTERONE; DIABETES MELLITUS; DIET; DIETARY FATS; EPIDIDYMIS; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, OBESE; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 23144457082     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870228     Document Type: Article

References (29)

1. Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 1979; 59: 719-809
2. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418-1421
3. La Fleur SE, Akana SF, Manalo SL, Dallman MF. Interaction between corticosterone and insulin in obesity: Regulation of lard intake and fat stores. Endocrinology 2004; 145: 2174-2185
4. Fehm HL, Born J, Peters A. Glucocorticoids and melanocortins in the regulation of body weight in humans. Horm Metab Res 2004; 36: 360-364
5. Parillo M, Riccardi G. Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. Br J Nutr 2004; 92: 7-19
6. Collins S, Martin TL, Surwit RS, Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 2004; 81: 243-248
7. Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C, Rönquist-Nii Y, Öhman B, Abrahmsén L. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 2002; 45: 1528-1532
8. Barf T, Vallgarda J, Emond R, Häggström C, Kurz G, Nygren A, Larwood V, Mosialou E, Axelsson K, Olsson R, Engblom L, Edling N, Rönquist-Nii Y, Öhman B, Alberts P, Abrahmsén L. Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. J Med Chem 2002; 45: 3813-3815
9. Alberts P, Nilsson C, Selén G, Engblom LOM, Edling NHM, Norling S, Klingström G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Öhman B, Björkstrand E, Abrahmsén LB. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003; 144: 4755-4762
10. Shackleton CHL. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 1993; 45: 127-140
11. Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR, Holmes MC. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary- adrenal axis: Analysis of 11beta-HSD-1-deficient mice. Endocrinology 2001; 142: 114-120
12. Thupari JN, Kim EK, Moran TH, Ronnett GV, Kuhajda FP. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. J Physiol Endocrinol Metab 2004; 287: E97-E104
13. Dubuc PU, Ristimaki S, Cahn PJ, Willis PL. Glucose tolerance in aging obese (ob/ob) and lean mice. Horm Metab Res 1983; 15: 120-123
14. Saito M, Bray GA. Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice. Endocrinology 1983; 113: 2181-2185
15. Herberg L, Kley HK. Adrenal function and the effect of a high-fat diet on C57BL/6J and C57BL/6J-ob/ob mice. Horm Metab Res 1975; 7: 410-415
16. Dutta D, Sharma R. Regulation of hepatic glucocorticoid receptors in mice during dietary restriction. Horm Metab Res 2003; 35: 415-420
17. Seckl JR, Chapman KE. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase. Eur J Biochem 1997; 249: 361-364
18. Stewart PM, Krozowski ZS. 11Beta-Hydroxysteroid dehydrogenase. Vitam Horm 1999; 57: 249-324
19. Nobel S, Abrahmsén L, Oppermann U. Metabolic conversion as a pre-receptor control mechanism for lipophilic hormones. Eur J Biochem 2001; 268: 4113-4125
20. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170
21. Morton NM, Ramage L, Seckl JR. Down-regulation of adipose 11 beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: A potential adaptive mechanism counteracting metabolic disease. Endocrinology 2004; 145: 2707-2712
22. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CR. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 1995; 80: 3155-3159
23. Walker BR, Seckl JR. 11Beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease. Expert Op Therap Targets 2003; 7: 771-783
24. Stulnig TM, Waldhäusl W. 11Beta-hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia 2004; 47: 1-11
25. Surwit RS, Wang SY, Petro AE, Sanchis D, Raimbault S, Ricquier D, Collins S. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci USA 1998; 95: 4061-4065
26. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fiévet C, Walker BR, Flier JS, Mullins JJ, Seckl JR. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004; 53: 931-938
27. Liu Y, Nakagawa Y, Wang Y, Li R, Li X, Ohzeki T, Friedman TC. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice. Diabetes 2003; 52: 1409-1416
28. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CHL, Stewart PM. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature Gen 2003; 34: 434-439
29. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Rev 2004; 25: 831-866